Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oystein Flesland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 30, 2008
Commentary on the International Course on Practice and Quality Assurance in Transfusion Medicine in Norway, May 2007Oystein Flesland, Joseph Sweeney, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2005
Hemovigilance in NorwayAurora Espinosa, Christine Torsvik Steinsvåg, Oystein Flesland
Current Opinion in Hematology|October 4, 2008
Indications for use and cost-effectiveness of pathogen-reduced ABO-universal plasmaBjarte G Solheim, Rangini Chetty, Oystein Flesland
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Guidelines for transfusion in NorwayTor Hervig, Oystein Flesland, Vibeke Svenningsen, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 8, 2003
Donor lymphocytes transferred with the graft to kidney recipients. Potential for establishing microchimerismOystein Flesland, Per F Pfeffer, Bjarte G Solheim, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentratesOystein Flesland, Lisa S K Ip, Anne S Storlien, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 30, 2008
Commentary on the International Course on Practice and Quality Assurance in Transfusion Medicine in Norway, May 2007Oystein Flesland, Joseph Sweeney, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2005
Hemovigilance in NorwayAurora Espinosa, Christine Torsvik Steinsvåg, Oystein Flesland
Current Opinion in Hematology|October 4, 2008
Indications for use and cost-effectiveness of pathogen-reduced ABO-universal plasmaBjarte G Solheim, Rangini Chetty, Oystein Flesland
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Guidelines for transfusion in NorwayTor Hervig, Oystein Flesland, Vibeke Svenningsen, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 8, 2003
Donor lymphocytes transferred with the graft to kidney recipients. Potential for establishing microchimerismOystein Flesland, Per F Pfeffer, Bjarte G Solheim, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentratesOystein Flesland, Lisa S K Ip, Anne S Storlien, et al.
Pageof 1